Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles

References

• DunnCJWagstaffAJPerryCMCyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral®) in organ transplantationDrugs2001611957201611708766
   PubMed Web of Science ®Google Scholar
• HebertMFContributions of hepatic and intestinal matabolism and Pglycoprotein to cyclosporin ans tacrolimus oral drug deliveryAdv Drug Deliv Rev19972720121410837558
   PubMed Web of Science ®Google Scholar
• TjaiJFWebberIRBackDJCyclosporin metabolism by the gastrointestinal mucosaBr J Clin Pharmacol1991313443462054274
   PubMed Web of Science ®Google Scholar
• NobleSMarkhamACyclosporin: a review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral®)Drugs1995509249418586033
   PubMed Web of Science ®Google Scholar
• VonderscherJMeinzerARationale for the development of Sandimmun NeoralTransplant Proc199426292529277940924
   PubMed Web of Science ®Google Scholar
• MuellerEAKovarikJMvan BreeJBImproved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulationPharm Res1994113013048165192
   PubMed Web of Science ®Google Scholar
• DaiJNagaiTWangXpH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine AInt J Pharm200428022924015265562
   PubMed Web of Science ®Google Scholar
• WangXQDaiJDChenZBioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administrationJ Control Release20049742142915212874
   PubMed Web of Science ®Google Scholar
• WangXQHuangJDaiJDLong-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloidInt J Pharm200632214615316787721
   PubMed Web of Science ®Google Scholar
• ItaliaJLBhattDKBhardwajVPLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmun NeoralJ Control Release200711919720617399839
   PubMed Web of Science ®Google Scholar
• El-ShabouriMHPositively charged nanoparticles for improving the oral bioavailability of cyclosporin-AInt J Pharm200224910110812433438
   PubMed Web of Science ®Google Scholar
• MüllerRHRungeSRavelliVOral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystalsInt J Pharm2006317828916580159
   PubMed Web of Science ®Google Scholar
• AliabadiHMBrocksDRLavasanifarAPolymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistributionBiomaterials2005267251725916005061
   PubMed Web of Science ®Google Scholar
• GuoJWuTPingQSolubilization and pharmacokinetic behaviors of sodium cholate/lecithin-mixed micelles containing cyclosporine ADrug Deliv200512353915801719
   PubMed Web of Science ®Google Scholar
• LeeEJLeeSWChoiHGBioavailability of cyclosporin A dispersed in sodium lauryl sulfate-dextrin based solid microspheresInt J Pharm200121812513111337156
   PubMed Web of Science ®Google Scholar
• GuoJPingQChenYPharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun NeoralInt J Pharm2001216172111274802
   PubMed Web of Science ®Google Scholar
• ShahNMParikhJNamdeoAPreparation, characterization and in vivo studies of proliposomes containing Cyclosporine AJ Nanosci Nanotechnol200662967297317048505
   PubMed Web of Science ®Google Scholar
• LiuCWuJShiBEnhancing the bioavailability of cyclosporine a using solid dispersion containing polyoxyethylene (40) stearateDrug Dev Ind Pharm20063211512316455610
   PubMed Web of Science ®Google Scholar
• ChenMCWangJLTzenJTElevating bioavailability of cyclosporine a via encapsulation in artificial oil bodies stabilized by caleosinBiotechnol Prog2005211297130116080714
   PubMed Web of Science ®Google Scholar
• KimSJChoiHKLeeYBPharmacokinetic and pharmacodynamic evaluation of cyclosporin A O/W-emulsion in ratsInt J Pharm200224914915612433443
   PubMed Web of Science ®Google Scholar
• ThomsonABSchoellerCKeelanMLipid absorption: passing through the unstirred layers, brush-border membrane, and beyondCan J Physiol Pharmacol1993715315558306192
   PubMed Web of Science ®Google Scholar
• PorterCJTrevaskisNLCharmanWNLipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugsNat Rev Drug Discov2007623124817330072
   PubMed Web of Science ®Google Scholar
• BarauskasJJohnssonMTibergFSelf-aseembled lipid supersture beyond vesicles and liposomesNano Lett200551615161916089498
   PubMed Web of Science ®Google Scholar
• YangDArmitageBMarderSRCubic liquid-crystalline nanoparticlesAngew Chem Int Ed20044344024409
   PubMed Web of Science ®Google Scholar
• EspositoECortesiRDrechslerMCubosome dispersions as delivery systems for percutaneous administration of indomethacinPharm Res2005222163217316267633
   PubMed Web of Science ®Google Scholar
• GargGSarafSSarafSCubosomes: an overviewBiol Pharm Bull20073035035317268078
   PubMed Web of Science ®Google Scholar
• ChungHKimJUmJYSelf-asembled “nanocubicle” as a carrier for peroral insulin deliveryDiabetologia20024544845111914752
   PubMed Web of Science ®Google Scholar
• UmJYChungHKimKSIn vitro cellular interaction and absorption of dispersed cubic particlesInt J Pharm2003253718012593938
   PubMed Web of Science ®Google Scholar
• LaiJChenJLuYGlyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatinAAPS PharmSciTech20091096096619636709
   PubMed Web of Science ®Google Scholar
• GustafssonJLjusberg-WahrenHAlmgrenMCubic lipid-water phase dispersed into submicron particlesLangmuir19961246114613
   Web of Science ®Google Scholar
• JinYAiPXinRMorphological transformation of self-assembled nanostructures prepared from cholesteryl acyldidanosine and the optimal formulation of nanoparticulate system: Effect of solvents, acyl chain length and poloxamer 188J Colloid Interf Sci2008326275282
   Web of Science ®Google Scholar
• MissirlisDKawamuraRTirelliNDoxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticlesEur J Pharm Sci20062912012916904301
   PubMed Web of Science ®Google Scholar
• ChimalakondaAPShahRBMehvarRHigh-performance liquid chromatographic analysis of cyclosporin A in rat blood and liver using a commercially available internal standardJ Chromatogr B2002772107114
   PubMed Web of Science ®Google Scholar
• KatneniKCharmanSAPorterCJAn evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicityJ Pharm Pharmacol2008601311131918812024
   PubMed Web of Science ®Google Scholar
• KorjamoTHeikkinenATMönkkönenJAnalysis of unstirred water layer in in vitro permeability experimentsJ Pharm Sci2009984469447919653267
   PubMed Web of Science ®Google Scholar
• BoydBJWhittakerDVKhooSMLyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systemsInt J Pharm200630921822616413980
   PubMed Web of Science ®Google Scholar
• BoydBJKhooSMWhittakerDVA lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in ratsInt J Pharm2007340526017467935
   PubMed Web of Science ®Google Scholar
• LeeKWNguyenTHHanleyTNanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugsInt J Pharm200936519019918790030
   PubMed Web of Science ®Google Scholar